Correlations between homocysteine levels and atherosclerosis in Japanese type 2 diabetic patients

Metabolism: Clinical and Experimental

Volumn 56, Issue 10, 2007, Pages 1390-1395

  Anan, Futoshi ^a,b   Masaki, Takayuki ^b   Umeno, Yoshikazu ^a   Yonemochi, Hidetoshi ^b   Eshima, Nobuoki ^b   Saikawa, Tetsunori ^b   Yoshimatsu, Hironobu ^b  

^a OITA RED CROSS HOSPITAL   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HOMOCYSTEINE; INSULIN;

ADULT; AORTA; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPANESE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSCILLOMETRY; PRIORITY JOURNAL; PULSE WAVE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

AGED; ANTHROPOMETRY; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HOMEOSTASIS; HOMOCYSTEINE; HUMANS; INSULIN RESISTANCE; JAPAN; MALE; MIDDLE AGED;

EID: 34548630223     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.05.010     Document Type: Article

References (37)

1. Nygard O., Nordrehaug J.E., Refsum H., et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337 (1997) 230-236
2. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J 325 (2002) 1202-1206
3. Zureik M., Bureau J.M., Temmar M., et al. Echogenic carotid plaques are associated with aortic arterial stiffness in subjects with subclinical carotid atherosclerosis. Hypertension 41 (2003) 519-527
4. Laurent S., Boutouyrie P., Asmar R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
5. Tomiyama H., Yamashina A., Arai T., et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement-a survey of 12517 subjects. Atherosclerosis 166 (2003) 303-309
6. Yamashina A., Tomiyama H., Arai T., et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 26 (2003) 615-622
7. Yamashina A., Tomiyama H., Takeda K., et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25 (2002) 359-364
8. Tomiyama H., Koji Y., Yambe M., et al. Brachial-ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ J 69 (2005) 815-822
9. Reaven G.M. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
10. DeFronzo R.A., and Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 (1991) 173-194
11. Giltay E.J., Hoogeveen E.K., Elberts J.M., et al. Insulin resistance is associated with elevated plasma homocysteine levels in healthy, non-obese subjects. Arteriosclerosis 139 (1998) 197-198
12. Emoto M., Kanda H., Shoji T., et al. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 24 (2001) 533-538
13. Liao D., Sloan R.P., Cascio W.E., et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 21 (1998) 2116-2122
14. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
15. Friedwald W.T., Levi R.I., and Fredrickson D.C. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 18 (1972) 499-502
16. Donnelly J.G., and Pronovost C. Evaluation of the Abbott IMx fluorescence polarization immunoassay and the Bio-Rad enzyme immunoassay for homocysteine: comparison with high-performance liquid chromatography. Ann Clin Biochem 37 (2000) 194-198
17. Davies L., Wilmshurst E.G., McElduff A., et al. The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes. Diabetes Care 24 (2001) 1805-1809
18. Cohen J.A., Jeffers B.W., Stabler S., et al. Increasing homocysteine levels and diabetic autonomic neuropathy. Auton Neurosci 87 (2001) 268-273
19. Spoelstra-De Man A.M., Smulders Y.M., Dekker J.M., et al. Homocysteine levels are not associated with cardiovascular autonomic function in elderly Caucasian subjects without or with type 2 diabetes mellitus: Hoorn study. J Intern Med 258 (2005) 536-543
20. 123I] metaiodobenzylguanidine. Diabetes 41 (1992) 1069-1075
21. Schnell O., Muhr D., Weiss M., et al. Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus. J Diabetes Complications 11 (1997) 307-313
22. Weir D.G., and Scott J.M. The biochemical basis of neuropathy in cobalamin deficiency. Bailliere's Clin Heamatol 8 (1995) 479-497
23. Chowdhary S., Vaile J.C., Fletcher J., et al. Nitric oxide and cardiac autonomic control in humans. Hypertension 36 (2000) 264-269
24. Davis J.I., Band M., Morris A., et al. Spironolactone impairs endothelial dysfunction and heart rate variability in patients with type 2 diabetic. Diabetologia 47 (2004) 1687-1694
25. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 98 (1996) 5-7
26. Tirosh A., Potashnik R., Bashan N., et al. Oxidant stress disrupts insulin-induced redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and glut4 translocation. J Biol Chem 274 (1999) 10595-10602
27. Najib S., and Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin signaling and glutathione has a protective effects. J Mol Endocrinol 27 (2001) 85-91
28. Jacobs R.L., House J.D., Brosnan M.E., et al. Effects of streptozotocin-induced diabetes and insulin treatment on homocysteine metabolism rat. Diabetes 47 (1998) 1967-1970
29. Fonseca V., Dicker-Brown A., Ranganathan S., et al. Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. Metabolism 49 (2000) 736-741
30. Wheeler D.C., Townend J.N., and Landray M.J. Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study. Kidney Int Suppl 84 (2003) S201-S203
31. Gavras H.P. Issues in hypertension: drug tolerability and special populations. Am J Hypertens 14 Pt 2 (2001) 231S-236S
32. Lender D., Arauz-Pacheco C., Breen L., et al. A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients. Am J Hypertens 12 (1999) 298-303
33. Anan F., Takahashi N., Ooie T., et al. Effects of valsartan and perindopril combination therapy on left ventricular and aortic arterial stiffness in patients with essential hypertension. Eur J Clin Pharmacol 61 (2005) 353-359
34. Munakata M., Nagasaki A., Nunokawa T., et al. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients. Am J Hypertens 17 (2004) 1050-1055
35. Moriyama Y., Okamura T., Kajinami K., et al. Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. Atherosclerosis 164 (2002) 321-328
36. Frosst P., Blom H.J., Milos R., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
37. Rsenberg N., Murata M., Ikeda Y., et al. The frequent 5, 10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in White, Japanese, and Africans. Am J Hum Genet 70 (2002) 758-762